Cargando…
Gene signature reveals decreased SOX10-dependent transcripts in malignant cells from immune checkpoint inhibitor-resistant cutaneous melanomas
Evidence is mounting for cross-resistance between immune checkpoint and targeted kinase inhibitor therapies in cutaneous melanoma patients. Since the loss of the transcription factor, SOX10, causes tolerance to MAPK pathway inhibitors, we used bioinformatic techniques to determine if reduced SOX10 e...
Autores principales: | Purwin, Timothy J., Caksa, Signe, Sacan, Ahmet, Capparelli, Claudia, Aplin, Andrew E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10450419/ https://www.ncbi.nlm.nih.gov/pubmed/37636077 http://dx.doi.org/10.1016/j.isci.2023.107472 |
Ejemplares similares
-
SOX10 requirement for melanoma tumor growth is due, in part, to immune-mediated effects
por: Rosenbaum, Sheera R., et al.
Publicado: (2021) -
Targeting SOX10-deficient cells to reduce the dormant-invasive phenotype state in melanoma
por: Capparelli, Claudia, et al.
Publicado: (2022) -
The future of targeted kinase inhibitors in melanoma
por: Caksa, Signe, et al.
Publicado: (2022) -
ERK-mediated phosphorylation regulates SOX10 sumoylation and targets expression in mutant BRAF melanoma
por: Han, Shujun, et al.
Publicado: (2018) -
MIG6 is MEK-regulated and affects EGF-induced migration in mutant NRAS melanoma
por: Vu, Ha Linh, et al.
Publicado: (2015)